A Prospective Randomized Multicentre Clinical Trial Comparing Open Reduction Internal Fixation With Primary Subtalar Fusion in Patients With Severely Comminuted (Sanders IV), Displaced, Intra-articular Fractures of the Calcaneus
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fractures, Comminuted
- Sponsor
- University of Calgary
- Enrollment
- 26
- Locations
- 4
- Primary Endpoint
- General Health Survey - SF-36
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
A multicentre randomized controlled trial that will be conducted at Level 1 trauma centres across Canada. It will compare patients who receive open reduction, internal fixation for Sanders IV calcaneal fractures to patients who receive primary subtalar fusion for the same type of fracture. Patients will be followed up for a period of two years from the time of operation with evaluations being performed at 5 time points: 6 weeks, 3 months, 6 months, 12 months, and 24 months.
Investigators
Richard Buckley
Clinical Professor, Section of Orthopaedics, Department of Surgery
University of Calgary
Eligibility Criteria
Inclusion Criteria
- •patients with Sanders IV displaced intra-articular calcaneal fracture
- •males and females aged 16-59 inclusive
- •ability to provide informed consent
- •available for follow-up for at least 2 years after injury
Exclusion Criteria
- •medical contraindications to surgery
- •previous calcaneal pathology (infection, tumor, etc)
- •co-existent foot or ipsilateral lower limb injury
- •open calcaneal fracture
- •injury greater than 3 weeks old
- •head injured patients
- •inability to obtain pre-operative CT scan or accurately classify the fractures according to the Sanders classification system
- •inability to comply with advice to diminish smoking after the injury
- •metal allergy
- •extremely comminuted intra-articular fractures of the calcaneus deemed impossible to reconstruct by the treating surgeon
Outcomes
Primary Outcomes
General Health Survey - SF-36
Time Frame: 6 months, 12 months, and 24 months
Secondary Outcomes
- Validated Visual Analogue Scale(6 months, 12 months, and 24 months)
- Musculoskeletal Function Assessment(6 months, 12 months, and 24 months)